MSC-derived EVs are enriched in anti-angiogenic miRNAs such as miRNA-16 that is internalized by breast cancer cells and suppress vascular endothelial growth factor (VEGF) expression in recipient tumor cells in vitro as well as in vivo and inhibit angiogenesis [156]. This evidence concerns the gene VEGFA and breast cancer.